INTRODUCTION
The desirability of good correlations of variables derived from in vitro dissolution rates with variables derived from in vivo testing in human volunteers is well established in biopharmaceutics. Some good quantitative correlations have been reviewed (1) .
This article presents a new type of in vitro-in vivo correlation based on parameters which are estimated by the logarithmic probability method of Wagner (2).
EXPERIMENTAL

In Vitro Studies
In vitro dissolution tests were performed on ten commercial 5-mg prednisone tablets made by different manufacturers. The dissolution medium was deaerated water at 37~ and the spin filter apparatus of Shah et al. (3) was used.
In Vivo Studies
Three separate bioavailability studies were performed in healthy adult male volunteers. The first study was a nine-subject three-treatment crossover, while the second and third studies were 12-subject four-treatment crossovers. A 5-mg prednisone tablet manufactured by the Schering Corporation was used as a treatment in both the first and third studies. Doses of 10 mg of prednisone were administered orally and venous blood samples were collected. Plasma concentrations of prednisolone, the active metabolite of prednisone, were determined by a radioimmunoassay method. The details and results of these studies have been presented elsewhere (4, 5) ; the manufacturer and lot numbers of the prednisone tablets are given in those reports.
Treatment of Data
One in vivo parameter was the time to reach half-maximal plasma concentration of prednisolone. The in vitro parameters, correlated with this in vivo parameter, were the times to dissolve 16% or 50% of the labeled amount of prednisone in water at 37~ using the spin filter apparatus. Both parameters were estimated by the logarithmic-probability method of Wagner (2) .
The logarithmic-probability method consists of plotting percent of label dissolved, or percent of peak plasma concentration, on the probability axis of logarithmic-probability graph paper and time on the logarithmic axis. The values of the parameters can then be estimated from the equations shown below.
This procedure has been simplified by employing an electronic calculator with a program which calculates the area under the standard (normal) probability distribution function (Z) and with a second program which calculates the parameters of a linear least-square line. The percentages of label dissolved, or percentages of peak plasma concentration values, are converted to Z values, then the least-squares Z vs. log t line is calculated, where t equals time. This line has an equation of the form Z = I + slog t (1) where I is the intercept and s is the slope. The median (50 %) point is then calculated by means of tso ~ = antilog (-1/s) (2) since Z = 0 for the median. The estimated time to dissolve 16 % of label is calculated from t16~*=antil~ -I-s 1}
Correlation coefficients were calculated for the average plasma prectnisolone concentration at both 0.5 and 1 hr and the percent of the labeled amount of prednisolone dissolved in water at 37~ in 20 rain in the spin filter apparatus. Table I presents the mean values of six tablets of each lot for percent of labeled amount of prednisone dissolved in the spin filter apparatus of Shah. Measurements were made at 400 rpm for 60 min, then the stirrer speed was increased to 800 rpm and absorbance readings were taken until a constant absorbance or "infinity" value was obtained. All of the tablets tested released 
RESULTS AND DISCUSSION
In Vitro Studies
In Vit,o Studies
The results of the three bioavailability studies which were performed have been reported previously (4, 5) .
Correlations
An example of the logarithmic-probability graphs for the calculation of time to reach half-maximal plasma concentration is shown in Fig. 1 . This figure illustrates the technique with the average plasma prednisone concentrations following oral administration of four of the tablets. In the actual application of the method, the individual subject or tablet data were averaged and prednisolone, not prednisone, plasma concentrations were employed. Table II lists the average in vitro and in vivo parameters and their 95 confidence intervals for the ten commercial 5-rag prednisone tablets tested.
The in vitro-in vivo correlation based on the time to reach half-maximal plasma concentrations and the time to dissolve 16~o of the labeled amount of prednisone in the spin filter apparatus is shown in Fig. 2 . Tablets S, U, L, B, Mc, and N gave the same in vivo parameter within error (i.e., the averages did not differ significantly). The average in vivo parameter for these six tablets is shown as the dotted line drawn through these values. This agrees with theory in that there will be some range of in vitro rates of dissolution where the in vivo measurement will not differ significantly, there will be some critical value of the in vitro parameter, and then further decrease in rate of dissolution will cause a progressive change in the in vivo parameter. In this case, the critical in vitro rate of dissolution appears to be near that of tablet N. Further increase in the in vitro parameter appeared to give a linear relationship between time to reach half-maximal plasma concentration and the logarithm of the time to dissolve 16 ~ of labeled amount of prednisone in deaerated water at 37~ in the spin filter apparatus. The least-squares line through these points has the equation ~= 8.84 + 31.31og t16 ~ (r = 0.959, p < 0.001)
where ~ is the estimated average time to reach half-maximal plasma prednisolone concentration.
The correlation of the same in vivo parameter with the time to dissolve 50~ of the labeled amount of prednisone is shown in Fig. 3 . The same phenomenon of a critical value of the in vitro parameter is seen, but the correlation is not as good (lower r value) as the previous one. The equation In interpreting Figs. 1-5 it should be noted that one of tablet H or M was previously reported (4) to have failed in clinical use. Hence it would appear reasonable to us to set dissolution rate specifications for prednisone tablets using tablet N as a "cutoff" point. The upper levels of the 95 confidence intervals of the averages for these tablets are 16 ~o dissolved in 6.9 min and 50~o dissolved in 15.4 min (Table II) ; in 15 min the mean percent dissolved for this tablet was 50.7 ~ and in 20 min the mean percent dissolved was 66.2 ~o (Table I) .
The National Center for Drug Analysis of the Food and Drug Administration has also obtained in vitro rate of dissolution data on the same prednisone tablets as those discussed here using paddle stirrer and the USP methods. Those data will be the subject of a separate report. 
